Arundathy N. Pandite, Chief Medical Officer at Shattuck Labs, sold 30,000 shares of common stock on May 12, 2026, totaling $198,300. The shares were sold at a weighted average price of $6.61 per share.
The insider sale follows remarkable stock performance, with shares up 574% over the past year and 255% in the last six months. The sale was executed under a Rule 10b5-1 trading plan adopted on February 2, 2026.
After the transaction, Pandite directly owns 166,219 shares. According to Bond.az analysis, the stock appears overvalued relative to fair value, though analyst targets range from $7 to $18.
